121 related articles for article (PubMed ID: 3164500)
21. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations.
Winklhofer-Roob BM; van't Hof MA; Shmerling DH
Am J Clin Nutr; 1996 May; 63(5):722-8. PubMed ID: 8615355
[TBL] [Abstract][Full Text] [Related]
22. Complex Relation Between Diet and Phospholipid Fatty Acids in Children With Cystic Fibrosis.
Moukarzel S; Dyer RA; Innis SM
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):598-604. PubMed ID: 28333826
[TBL] [Abstract][Full Text] [Related]
23. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
Coste TC; Deumer G; Reychler G; Lebecque P; Wallemacq P; Leal T
Clin Chem; 2008 Feb; 54(2):388-95. PubMed ID: 18089657
[TBL] [Abstract][Full Text] [Related]
24. Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?
Hubbard VS; Dunn GD; di Sant'Agnese PA
Lancet; 1977 Dec 24-31; 2(8052-8053):1302-4. PubMed ID: 74723
[TBL] [Abstract][Full Text] [Related]
25. Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients.
Gibson RA; Teubner JK; Haines K; Cooper DM; Davidson GP
J Pediatr Gastroenterol Nutr; 1986; 5(3):408-15. PubMed ID: 3723260
[TBL] [Abstract][Full Text] [Related]
26. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation.
Winklhofer-Roob BM; Ziouzenkova O; Puhl H; Ellemunter H; Greiner P; Müller G; van't Hof MA; Esterbauer H; Shmerling DH
Free Radic Biol Med; 1995 Dec; 19(6):725-33. PubMed ID: 8582644
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of fatty acid desaturation and elongation to plasma zinc concentration: a randomised controlled trial in Beninese children.
Chimhashu T; Malan L; Baumgartner J; van Jaarsveld PJ; Galetti V; Moretti D; Smuts CM; Zimmermann MB
Br J Nutr; 2018 Mar; 119(6):610-619. PubMed ID: 29352828
[TBL] [Abstract][Full Text] [Related]
28. Serum fatty acid profiles in cystic fibrosis patients and their parents.
Christophe AB; Warwick WJ; Holman RT
Lipids; 1994 Aug; 29(8):569-75. PubMed ID: 7990664
[TBL] [Abstract][Full Text] [Related]
29. Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.
Collins CE; Quaggiotto P; Wood L; O'Loughlin EV; Henry RL; Garg ML
Lipids; 1999 Jun; 34(6):551-6. PubMed ID: 10405967
[TBL] [Abstract][Full Text] [Related]
30. Antioxidant status in patients with cystic fibrosis.
Madarasi A; Lugassi A; Greiner E; Holics K; Biró L; Mozsáry E
Ann Nutr Metab; 2000; 44(5-6):207-11. PubMed ID: 11146325
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis.
Hubbard VS; Dunn GD
Clin Chim Acta; 1980 Mar; 102(1):115-8. PubMed ID: 7389104
[TBL] [Abstract][Full Text] [Related]
32. Fatty acid composition of plasma lipids in Nigerian children with protein-energy malnutrition.
Koletzko B; Abiodun PO; Laryea MD; Bremer HJ
Eur J Pediatr; 1986 Apr; 145(1-2):109-15. PubMed ID: 3089792
[TBL] [Abstract][Full Text] [Related]
33. Serum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis.
Olveira G; Dorado A; Olveira C; Padilla A; Rojo-Martínez G; García-Escobar E; Gaspar I; Gonzalo M; Soriguer F
Br J Nutr; 2006 Aug; 96(2):343-9. PubMed ID: 16923229
[TBL] [Abstract][Full Text] [Related]
34. In vitro study of the incorporation and transport of nonesterified fatty acids into the phospholipids of the red blood cell membranes of cystic fibrosis patients.
Rogiers V; Mandelbaum I; Mozes N; Vertongen F; Dab I; Crokaert R; Vis HL
Pediatr Res; 1982 Sep; 16(9):761-8. PubMed ID: 7133810
[TBL] [Abstract][Full Text] [Related]
35. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
[TBL] [Abstract][Full Text] [Related]
36. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
[TBL] [Abstract][Full Text] [Related]
37. Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
Rust P; Eichler I; Renner S; Elmadfa I
Int J Vitam Nutr Res; 1998; 68(2):83-7. PubMed ID: 9565821
[TBL] [Abstract][Full Text] [Related]
38. Plasma fatty acid composition of breast-feeding Sudanese women.
el-Amin EO; el-Karib AO; Ahmed MH; Leichsenring M; Laryea MD; Bremer HJ
Trop Med Parasitol; 1988 Sep; 39(3):199-202. PubMed ID: 3143148
[TBL] [Abstract][Full Text] [Related]
39. Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis.
Underwood BA; Denning CR; Navab M
Ann N Y Acad Sci; 1972 Dec; 203():237-47. PubMed ID: 4512105
[No Abstract] [Full Text] [Related]
40. Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: are they related to clinical outcomes?
Colombo C; Bennato V; Costantini D; Valmarana L; Daccò V; Zazzeron L; Ghisleni D; Bruzzese MG; Scaglioni S; Riva E; Agostoni C
J Pediatr Gastroenterol Nutr; 2006 Nov; 43(5):660-5. PubMed ID: 17130745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
